![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Moderate Hepatic Impairment Does not Affect Doravirine Pharmacokinetics
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV
& Hepatitis Therapy (IWCPHIVHT) - May 26-28, 2015 Washington, DC, USA
Sauzanne Khalilieh,1 Ka Lai Yee,1 Rachel Liu,1 Li Fan,1 Patrice Auger,2 Ilias Triantafyllou,1 Daria Stypinski,2 Kenneth C Lasseter,3 Thomas Marbury,4 Marian Iwamoto1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA; 3Clinical Pharmacology of Miami, Inc., Miami, FL, USA; 4Orlando Clinical Research Center, Orlando, FL, USA
![Pharm1.gif](../images/060915/060815-3/Pharm1.gif)
![Pharm2.gif](../images/060915/060815-3/Pharm2.gif)
![Pharm3.gif](../images/060915/060815-3/Pharm3.gif)
![Pharm4.gif](../images/060915/060815-3/Pharm4.gif)
![Pharm5.gif](../images/060915/060815-3/Pharm5.gif)
![Pharm6.gif](../images/060915/060815-3/Pharm6.gif)
![Pharm7.gif](../images/060915/060815-3/Pharm7.gif)
![Pharm8.gif](../images/060915/060815-3/Pharm8.gif)
![Pharm9.gif](../images/060915/060815-3/Pharm9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|